We present the rare case of a fatal anaphylactic reaction to gadobutrol, a magnetic resonance imaging contrast agent, in a 42-year-old man. The patient underwent elective magnetic resonance imaging for diagnostic clarification of a suspicious finding in the abdomen. The patient had undergone contrast-enhanced computed tomography previously without the occurrence of any adverse effects. Adverse drug reactions in gadobutrol have a very low prevalence of 0.32%-3.5%, with serious adverse drug reactions in <0.1%. There are only a few cases of fatal anaphylactoid reactions to gadolinium-based contrast agents in general. However, if an anaphylactoid reaction occurs, it can present itself with a fulminant course within minutes
Anaphylactic reactions to neuromuscular blocking agents (NMBAs) can be severe and fatal. Two thousan...
Contrast-enhanced radiological examinations are important diagnostic tools in modern medicine. Curre...
PubMed ID: 29292188Background: Gadolinium-based contrast agents are relatively safe for use in magne...
We present the rare case of a fatal anaphylactic reaction to gadobutrol, a magnetic resonance imagin...
We report the case of a young adult which survived to anaphylactic shock caused by gadolinium-based ...
Acute respiratory distress syndrome (ARDS) is a medical emergency that threatens life. To this day, ...
The objective of this study was to evaluate the clinical safety of intravenous gadolinium-based cont...
Acute respiratory distress syndrome (ARDS) is a life-threatening medical emergency. The etiology of ...
We report a fatal intravenous ioversol administration in a 60-year old male patient. Although the in...
Acute respiratory distress syndrome is a sudden in onset, diffuse inflammatory form of lung injury w...
Anaphylaxis against gadolinium based contrast agents (GBCAs) has been reported in all severity grade...
Kounis syndrome [KS] is a hypersensitivity coronary disorder induced by various allergens. It is a r...
Objectives: Recent safety concerns regarding gadolinium-based contrast agents (GdCAs) concluded with...
A 49-year-old woman developed an anaphylactic reaction to Tc-99m macrosalb used for pulmonary scinti...
Ondansetron a selective 5-HT3 receptor antagonist has been widely used as a prophylactic antiemetic ...
Anaphylactic reactions to neuromuscular blocking agents (NMBAs) can be severe and fatal. Two thousan...
Contrast-enhanced radiological examinations are important diagnostic tools in modern medicine. Curre...
PubMed ID: 29292188Background: Gadolinium-based contrast agents are relatively safe for use in magne...
We present the rare case of a fatal anaphylactic reaction to gadobutrol, a magnetic resonance imagin...
We report the case of a young adult which survived to anaphylactic shock caused by gadolinium-based ...
Acute respiratory distress syndrome (ARDS) is a medical emergency that threatens life. To this day, ...
The objective of this study was to evaluate the clinical safety of intravenous gadolinium-based cont...
Acute respiratory distress syndrome (ARDS) is a life-threatening medical emergency. The etiology of ...
We report a fatal intravenous ioversol administration in a 60-year old male patient. Although the in...
Acute respiratory distress syndrome is a sudden in onset, diffuse inflammatory form of lung injury w...
Anaphylaxis against gadolinium based contrast agents (GBCAs) has been reported in all severity grade...
Kounis syndrome [KS] is a hypersensitivity coronary disorder induced by various allergens. It is a r...
Objectives: Recent safety concerns regarding gadolinium-based contrast agents (GdCAs) concluded with...
A 49-year-old woman developed an anaphylactic reaction to Tc-99m macrosalb used for pulmonary scinti...
Ondansetron a selective 5-HT3 receptor antagonist has been widely used as a prophylactic antiemetic ...
Anaphylactic reactions to neuromuscular blocking agents (NMBAs) can be severe and fatal. Two thousan...
Contrast-enhanced radiological examinations are important diagnostic tools in modern medicine. Curre...
PubMed ID: 29292188Background: Gadolinium-based contrast agents are relatively safe for use in magne...